MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.
VANCOUVER, British Columbia, Oct.
14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “ Company ” or “ MindBio ”), a biotechnology company advancing the commercialisation of AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce that it has completed the manufacture of its next-generation Edge AI Intoxication Detection Kiosk.
Read More
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.